Effect of inhaled corticosteroids on blood eosinophil count in steroid-naive patients with COPD

被引:39
作者
Kreindler, James L. [1 ]
Watkins, Michael L. [2 ]
Lettis, Sally [3 ]
Tal-Singer, Ruth [1 ]
Locantore, Nicholas [1 ]
机构
[1] GlaxoSmithKline Res & Dev Ltd, King Of Prussia, PA USA
[2] GlaxoSmithKline Res & Dev Ltd, Res Triangle Pk, NC USA
[3] GlaxoSmithKline Res & Dev Ltd, Uxbridge, Middx, England
来源
BMJ OPEN RESPIRATORY RESEARCH | 2016年 / 3卷 / 01期
关键词
D O I
10.1136/bmjresp-2016-000151
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Introduction: Sputum and blood eosinophil counts have attracted attention as potential biomarkers in chronic obstructive pulmonary disease (COPD). One question regarding the use of blood eosinophils as a biomarker in COPD is whether their levels are affected by the use of inhaled corticosteroids (ICS), which are commonly prescribed for COPD. Methods: We performed a retrospective analysis of peripheral blood leucocytes from a previously completed clinical trial that examined effects of ICS in steroid-naive patients with COPD. Results and conclusion: The data show that the ICS-containing treatment arms (containing fluticasone propionate) had a small effect on peripheral blood eosinophils in steroid-naive patients with COPD.
引用
收藏
页数:4
相关论文
共 10 条
  • [1] Blood Eosinophils to Direct Corticosteroid Treatment of Exacerbations of Chronic Obstructive Pulmonary Disease A Randomized Placebo-Controlled Trial
    Bafadhel, Mona
    McKenna, Susan
    Terry, Sarah
    Mistry, Vijay
    Pancholi, Mitesh
    Venge, Per
    Lomas, David A.
    Barer, Michael R.
    Johnston, Sebastian L.
    Pavord, Ian D.
    Brightling, Christopher E.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2012, 186 (01) : 48 - 55
  • [2] Sputum eosinophilia and the short term response to inhaled mometasone in chronic obstructive pulmonary disease
    Brightling, CE
    McKenna, S
    Hargadon, B
    Birring, S
    Green, R
    Siva, R
    Berry, M
    Parker, D
    Monteiro, W
    Pavord, ID
    Bradding, P
    [J]. THORAX, 2005, 60 (03) : 193 - 198
  • [3] ESTIMATES OF LOCATION BASED ON RANK-TESTS
    HODGES, JL
    LEHMANN, EL
    [J]. ANNALS OF MATHEMATICAL STATISTICS, 1963, 34 (02): : 598 - &
  • [4] Sputum inflammation predicts exacerbations after cessation of inhaled corticosteroids in COPD
    Liesker, Jeroen J. W.
    Bathoorn, Erik
    Postma, Dirkje S.
    Vonk, Judith M.
    Timens, Wim
    Kerstjens, Huib A. M.
    [J]. RESPIRATORY MEDICINE, 2011, 105 (12) : 1853 - 1860
  • [5] Mepolizumab Treatment in Patients with Severe Eosinophilic Asthma
    Ortega, Hector G.
    Liu, Mark C.
    Pavord, Ian D.
    Brusselle, Guy G.
    FitzGerald, J. Mark
    Chetta, Alfredo
    Humbert, Marc
    Katz, Lynn E.
    Keene, Oliver N.
    Yancey, Steven W.
    Chanez, Pascal
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2014, 371 (13) : 1198 - 1207
  • [6] Blood eosinophil counts, exacerbations, and response to the addition of inhaled fluticasone furoate to vilanterol in patients with chronic obstructive pulmonary disease: a secondary analysis of data from two parallel randomised controlled trials
    Pascoe, Steven
    Locantore, Nicholas
    Dransfield, Mark T.
    Barnes, Neil C.
    Pavord, Ian D.
    [J]. LANCET RESPIRATORY MEDICINE, 2015, 3 (06) : 435 - 442
  • [7] Sputum eosinophilia predicts benefit from prednisone in smokers with chronic obstructive bronchitis
    Pizzichini, E
    Pizzichini, MMM
    Gibson, P
    Parameswaran, K
    Gleich, GJ
    Berman, L
    Dolovich, J
    Hargreave, FE
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1998, 158 (05) : 1511 - 1517
  • [8] Blood Eosinophils: A Biomarker of Response to Extrafine Beclomethasone/Formoterol in Chronic Obstructive Pulmonary Disease
    Siddiqui, Selman H.
    Guasconi, Alessandro
    Vestbo, Jorgen
    Jones, Paul
    Agusti, Alvar
    Paggiaro, Pierluigi
    Wedzicha, Jadwiga A.
    Singh, Dave
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2015, 192 (04) : 523 - 525
  • [9] Eosinophilic airway inflammation and exacerbations of COPD: a randomised controlled trial
    Siva, R.
    Green, R. H.
    Brightling, C. E.
    Shelley, M.
    Hargadon, B.
    McKenna, S.
    Monteiro, W.
    Berry, M.
    Parker, D.
    Wardlaw, A. J.
    Pavord, I. D.
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2007, 29 (05) : 906 - 913
  • [10] Evaluation of COPD longitudinally to identify predictive surrogate end-points (ECLIPSE)
    Vestbo, J.
    Anderson, W.
    Coxson, H. O.
    Crim, C.
    Dawber, F.
    Edwards, L.
    Hagan, G.
    Knobil, K.
    Lomas, D. A.
    MacNee, W.
    Silverman, E. K.
    Tal-Singer, R.
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2008, 31 (04) : 869 - 873